MedPath

Prospective evaluation of preoperative navigated transcranial magnetic stimulation (nTMS) for neurosurgical procedures in language eloquent areas

Not Applicable
Recruiting
Conditions
D43.0
Brain, supratentorial
C71
Malignant neoplasm of brain
Registration Number
DRKS00025705
Lead Sponsor
Klinik für Neurochirurgie Klinikum Nürnberg Paracelsus Medizinische Privatuniversität
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

supratentorial location of the tumor

language eloquent tumor or patient has language impairment

proposed entity: primary or secondary brain tumor

all lesions of that patient are treated surgically

Mini Mental Status Examination >= 20 points

Exclusion Criteria

patients not eligible for MRI
patients with CSF fluid diversion
patients with implanted devices for neuromodulation or deep brain stimulation
patients who cannot consent
patient refuses participation
pregnant or breast-feeding patients
patients with exclusively infratentorial lesions
patients with meningiomas as lesion to be treated
patients on dialysis
patients with coronary heart disease
patients with heart rhythm disorders (except AV-block °I)
patients with NYHA III and NYHA IV heart failure
patients not eligible for nTMS language testing in German language
patients not eligible for nTMs language testing due to high grade of aphasia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of tumor resection
Secondary Outcome Measures
NameTimeMethod
postoperative tumor volume (cm³) on postoperative MRI (24-72hrs postoperative) <br><br>postoperative langugae function (Token Test)<br>postoperative day 2, before discharge, at follow-up after 3-6 months<br><br>postoperative neurologic status (NIHSS) postoperative day 2, before discharge, at follow-up after 3-6 months<br><br>predictive value of nTMS-examinations for postoperative neurologic outcome
© Copyright 2025. All Rights Reserved by MedPath